InMed Pharmaceuticals Inc.INMNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-164.49%
↑ 12% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-187.21%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -164.49% | -12.0% |
| 2025 | -146.80% | +4.5% |
| 2024 | -153.64% | +18.4% |
| 2023 | -188.19% | +84.6% |
| 2022 | -1218.98% | - |
| 2021 | 0.00% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | - |
| 2017 | 0.00% | - |